A national resource for tomorrow’s treatments – Karolinska ATMP Center is now inaugurated
With a clear message of hope for the future and a powerful spirit of collaboration, the Karolinska ATMP Center in Flemingsberg was inaugurated at the end of August. The center is a collaboration between Karolinska Institutet and Karolinska University Hospital and will serve as a national resource for the production of advanced therapies (ATMPs), where research, clinical trials, and treatments work seamlessly together to deliver groundbreaking therapies to patients.
“While others back into the future, we lead the way forward—with curiosity, with science, with knowledge, but also compassion as our guiding star,”said Aida Hadžialić, Finance Regional Councilor and Chair of the Regional Executive Board in Region Stockholm, at the inauguration.
More than 600 participants from industry, academia, municipalities, and society gathered in Flemingsberg to celebrate the shared goal: accelerating the development and accessibility of tomorrow’s treatments.
“Advanced therapies represent a paradigm shift. They offer possibilities that were previously unimaginable,”stated Annika Östman Wernerson, President of Karolinska Institutet.
Throughout the day, ongoing research and breakthroughs were presented in cell and gene therapy, treatment of neonatal lung disease, Parkinson’s disease, and immunotherapies. The program highlighted the pioneering progress already being made within ATMP in Flemingsberg, where the center symbolizes a major investment in accelerating the work of future medicine even further. Knut Steffensen, Director of the Karolinska ATMP Center, summarized the vision:
“We will cure and alleviate tomorrow, what no one can cure and alleviate today.”
Throughout the day, ongoing research and breakthroughs were presented in cell and gene therapy, treatment of neonatal lung disease, Parkinson’s disease, and immunotherapies. The program highlighted the pioneering progress already being made within ATMP in Flemingsberg, where the center symbolizes a major investment in accelerating the work of future medicine even further. Knut Steffensen, Director of the Karolinska ATMP Center, summarized the vision:
Sydkoreanska spelinvesterare besökte Press Start Game Hub i Flemingsberg
En delegation av investerare från några av Sydkoreas ledande spelbolag besökte igår Press Start Game Hub i Flemingsberg, en växande hubb för spelinnovation och entreprenörskap i Europa. Besöket var en del av ett initiativ organiserat av Business Sweden, med syfte att stärka banden mellan den svenska och sydkoreanska spelindustrin.
OptiCell Solutions inleder forskningssamarbete med Karolinska Institutet
Med siktet inställt på att stötta akademi, sjukvård och industri i utvecklingen av framtidens cell- och genterapier startade OptiCell Solutions sin verksamhet i Flemingsberg förra året. Nyligen inledde de ett forskningssamarbete med Karolinska Institutet, och tar därmed ett stort kliv i önskad riktning.
Kungliga Operan och konstskola Idun Lovén skapar konst i Flemingsberg
I Flemingsberg förenas utbildning, konst och kultur på ett unikt sätt. Nu inleder Kungliga Operan och konstskola Idun Lovén ett samarbete där studenter får arbeta sida vid sida med professionella dekormålare och skapa en fondmålning som kommer att pryda operans foajé i Scenhuset i Flemingsberg.
